Feldan Therapeutics
Quebec
About Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $53.3M
- Last round: Series Unknown (Apr 2025)
- Website: feldan.com
- Phone: +1.418.872.7277
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/feldan-therapeutics-93826 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.